184 related articles for article (PubMed ID: 18513434)
1. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
Cheng M; Chen Y; Yu X; Tian Z; Wei H
BMC Cancer; 2008 May; 8():156. PubMed ID: 18513434
[TBL] [Abstract][Full Text] [Related]
2. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
Cui Y; Wang W; Yao S; Qiu Z; Cong L
J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
4. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
Yan L; Yao Y; Wang LH; Wang ML; Fu XH
Genet Mol Res; 2015 Nov; 14(4):15090-5. PubMed ID: 26634471
[TBL] [Abstract][Full Text] [Related]
5. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
Wang WB; Cui YG; Yao SY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
[TBL] [Abstract][Full Text] [Related]
6. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
[TBL] [Abstract][Full Text] [Related]
7. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
Tang Y; Xu L
J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
[TBL] [Abstract][Full Text] [Related]
8. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
9. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
Tan S; Cheng Z; Ma Y; Tan S; Yin Z; Hu W; Yu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1236-41. PubMed ID: 21200090
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between the mRNA levels of BCRP and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
Chen D; Han W; Wang P; Ma H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):202-207. PubMed ID: 36709941
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.
Lv M; Wu MZ; Zhao YJ; Yang DI; Wang EH; Wu GP
Respirology; 2011 Oct; 16(7):1076-80. PubMed ID: 21651644
[TBL] [Abstract][Full Text] [Related]
12. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].
Mitas M; Hoover L; Silvestri G; Reed C; Green M; Turrisi AT; Sherman C; Mikhitarian K; Cole DJ; Block MI; Gillanders WE
J Mol Diagn; 2003 Nov; 5(4):237-42. PubMed ID: 14573783
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.
Iwao K; Watanabe T; Fujiwara Y; Takami K; Kodama K; Higashiyama M; Yokouchi H; Ozaki K; Monden M; Tanigami A
Int J Cancer; 2001 Feb; 91(4):433-7. PubMed ID: 11251963
[TBL] [Abstract][Full Text] [Related]
14. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
[TBL] [Abstract][Full Text] [Related]
16. Expression of two basic mRNA biomarkers in peripheral blood of patients with non-small cell lung cancer detected by real-time rt-PCR, individually and simultaneously.
Karimi S; Mohamadnia A; Nadji SA; Yadegarazari R; Khosravi A; Bahrami N; Saidijam M
Iran Biomed J; 2015; 19(1):17-22. PubMed ID: 25605485
[TBL] [Abstract][Full Text] [Related]
17. WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.
Yang TM; Leu SW; Li JM; Hung MS; Lin CH; Lin YC; Huang TJ; Tsai YH; Yang CT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):919-24. PubMed ID: 19085002
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
Zhang P; Liu Y; Chen J; Song S; Shang Z
Zhongguo Fei Ai Za Zhi; 2006 Dec; 9(6):506-10. PubMed ID: 21182811
[TBL] [Abstract][Full Text] [Related]
19. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer and its relations to the micrometastasis in peripheral blood.
Jin Y; Xiong X; Su Y; Hu J; Tao X
J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):462-5. PubMed ID: 19662363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
